Cytosorbents Corporation (CTSO) vs Lifeward Ltd. (LFWD)

Cytosorbents Corporation and Lifeward Ltd. are both Medical Devices companies. Lifeward Ltd. is the larger, with a market value of $19.7M against $13.6M — 1.5× the size. Cytosorbents Corporation grew revenue faster over the last twelve months: 3.07% against −10.7%. Cytosorbents Corporation has the higher net margin (−48.9% vs −141.3%) and the higher return on invested capital (−66.9% vs −126.1%). Across the 17 metrics below, Cytosorbents Corporation leads on 14 and Lifeward Ltd. on 3.

Valuation

Metric CTSO LFWD Medical Devices median
P/E n/m n/m 22.18
P/S 0.37 0.90 2.70
P/B n/m 1.60 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 0.71 0.98 2.38
Earnings yield (132.42%) (240.64%) (8.22%)
Free cash flow yield (68.50%) (87.44%) (7.80%)

Profitability

Metric CTSO LFWD Medical Devices median
Gross margin 71.61% 35.95% 56.01%
Operating margin (34.74%) (104.25%) (15.03%)
Net margin (48.94%) (141.28%) (20.40%)
Free cash flow margin (25.32%) (78.34%) (7.24%)
Return on equity (336.17%) (225.65%) (15.32%)
Return on assets (42.38%) (99.81%) (19.72%)
Return on invested capital (66.90%) (126.06%) (10.33%)

Growth

Metric CTSO LFWD Medical Devices median
Revenue growth (TTM) 3.07% (10.68%) 8.80%
EPS growth (last fiscal year) 65.79% 57.07% —
Revenue growth, 5-year CAGR (2.00%) 38.06% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTSO LFWD Medical Devices median
Debt to equity (22.96) 0.70 0.07
Current ratio 0.66 2.33 2.50
Net debt to EBITDA (0.85) (0.02) 0.49

Dividend

Metric CTSO LFWD Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric CTSO LFWD Medical Devices median
Market cap 13.55m 19.74m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack